Difference between revisions of "Apligraf"

From IntactiWiki
Jump to navigation Jump to search
m (decapitalize category names)
m (remove <coauthors> parameter)
Line 23: Line 23:
  
 
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews
 
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews
  | last=
+
  |last=
  | first=
+
  |first=
| coauthors=
+
  |url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf
  | url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf
+
  |title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript
  | title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript
+
  |date=November 2011
  | date=November 2011
+
  |publisher=FDA
  | publisher=FDA
+
  |quote=
  | quote=
+
  |accessdate=2011-12-20
  | accessdate=2011-12-20
 
 
}}</ref>
 
}}</ref>
  

Revision as of 21:33, 19 October 2019

Apligraf is a synthetic skin created from harvested foreskins.[1] It is FDA approved,[2] and it is made and sold by Organogenesis, which a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.

Apligraph Oral

Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."[3]

Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf

References

  1. REFweb Apligraf: How Is It Made?, Organogenesis. Retrieved 6 March 2011.
    Quote: Human keratinocytes and fibroblasts are derived from neonatal foreskins
  2. REFweb Apligraf, Organogenesis. Retrieved 6 March 2011.
    Quote: Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
  3. REFnews (error)."November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript", FDA. Retrieved 20 December 2011.